Results 191 to 200 of about 131,324 (287)

Protein tyrosine phosphatases as emerging targets for cancer immunotherapy

open access: yesBritish Journal of Pharmacology, Volume 183, Issue 6, Page 1233-1249, March 2026.
Abstract Contemporary strategies in cancer immunotherapy, despite remarkable success, remain constrained by inherent limitations such as suboptimal patient responses, the emergence of drug resistance, and the manifestation of pronounced adverse effects. Consequently, the need for alternative strategies for immunotherapy becomes clear.
Zihan Qu, Jiajun Dong, Zhong‐Yin Zhang
wiley   +1 more source

Peptide-modified phase-transition nanoparticles co-deliver FTO siRNA and Ce6 for sonodynamic metabolism-immunotherapy of melanoma. [PDF]

open access: yesJ Nanobiotechnology
Li X   +15 more
europepmc   +1 more source

Long‐Term Trends in Juvenile Blue Crab Recruitment Patterns in a Wind‐Driven Estuary

open access: yesFisheries Oceanography, Volume 35, Issue 2, Page 225-236, March 2026.
ABSTRACT Conserving exploited marine species requires understanding population dynamics across life stages and habitats. This study analyzes juvenile blue crab (Callinectes sapidus) recruitment trends in North Carolina's Albemarle‐Pamlico Estuarine System.
Erin Voigt   +2 more
wiley   +1 more source

Correction: Inhibition of post-surgery tumour recurrence via a sprayable chemo-immunotherapy gel releasing PD-L1 antibody and platelet-derived small EVs. [PDF]

open access: yesJ Nanobiotechnology
Zhao J   +12 more
europepmc   +1 more source

Chemotherapeutic Spherical Nucleic Acids. [PDF]

open access: yesACS Nano
Luo T   +8 more
europepmc   +1 more source

Nanogel‐Mediated Immunotherapy to Tackle Cancer and Inflammatory Diseases

open access: yesChemistryEurope, Volume 4, Issue 2, February 2026.
Nanogels formed through self‐assembly, microemulsion, or precipitation polymerization method enable precise delivery of immunotherapeutic factors and immune cell targeting, thus effectively modulating immune responses. This review highlights recent advances in stimuli‐responsive nanogel design, underlying mechanisms, and their potentials to tackle ...
Ziwen Zhang   +7 more
wiley   +1 more source

mTORC2 inhibition reduces tumor burden via STAT1 activation and enhanced response to anti-PD-L1 therapy. [PDF]

open access: yesCell Death Dis
Gschwendtner A   +9 more
europepmc   +1 more source

Cytotoxicity of the coagulant Moringa oleifera lectin (cMoL) to B16-F10 melanoma cells.

open access: yesToxicology in Vitro, 2017
Luciana de Andrade Luz   +5 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy